Article
Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy.
American journal of physiology. Heart and circulatory physiology - 1 Nov 2010
Timofeyev Valeriy, Porter Cliff A, Tuteja Dipika, Qiu Hong, Li Ning, Tang Tong, Singapuri Anil, Han Pyung-Lim, Lopez Javier E, Hammond H Kirk, Chiamvimonvat Nipavan
Abstract excerpt
Adenylyl cyclase (AC) is the principal effector molecule in the β-adrenergic receptor pathway. AC(V) and AC(VI) are the two predominant isoforms in mammalian cardiac myocytes. The disparate roles among AC isoforms in cardiac hypertrophy and progression to heart failure have been under intense investigation. Specifically, the salutary effects resulting from the disruption of AC(V) have been established in multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
